We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Andrew Serafini Fenwick & West LLP

Results 1 to 1 of 1
Most popular |Most recent


IP provisions and ROI for state-funded stem cell-based products and technologies in California

USA - May 31 2012 The California Institute of Regenerative Medicine (CIRM) reaches the end of its initial charter in 2017 and recently published its Transition Plan....

Gene Yee.